TCF7L1 has been shown to repress expression of the Wnt antagonist, dickkopf-4 (DKK4), tumor suppressor ephrin type-B receptor 3 (EPHB3), and cancer stem cell marker leucine-rich repeat containing G-protein-coupled receptor 5 (LGR5)9,13,15. Here, LGR5 is linked to cancer.